Fact CheckerSign in

NCT07447908Recruiting

Ted Rogers Understanding of Exacerbations in Heart Failure 2: Monitor

Ted Rogers Understanding of Exacerbations in Heart Failure 2 (TRUE-HF2): Observational Study

Source: ClinicalTrials.gov · Last updated 6 Jul 2026

Brief summary (registry, in English)

Heart Failure (HF) is a complex disease associated with the highest burden of cost to the healthcare system. The cardiopulmonary exercise test (CPET) is instrumental in determining the prognosis of patients with HF. This multicentre study will validate whether aggregate biometric data from the Apple Watch combined with demographic, cardiac, and biomarker testing can improve our ability to predict heart failure outcomes among a diverse outpatient HF population.

Status (registry)
Recruiting
Study type
Observational
Enrollment
360 (estimated)
First submitted
25 Feb 2026
Start date
16 Jun 2026
Primary completion date
30 Sept 2029
Lead sponsor
University Health Network, Toronto
NCT number
NCT07447908

What you commit to

  • Study type: Observational
  • Planned participants: 360
  • From 16 Jun 2026 to the primary completion date, 30 Sept 2029
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • End stage renal disease requiring dialysis
  • Post heart transplant

Other

  • Unable to perform a CPET based on the standard protocol
  • Living with LVAD
  • MRP deems patient unfit for the study

Who the study is looking for

  • broad age range (\> 18 years of age)
  • NT-proBNP \> 400 or 1000 if in AF
  • Within 3 months post discharge from HF hospitalization/ HF ED visit/ HF rapid clinic visit with intensification of diuretic therapy
  • NYHA functional class I-IV, heart failure with reduced and preserved ejection fraction
  • Literacy in English
  • Patient provided informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Southlake Health
Coordinator of this site? Confirm its status
NewmarketCanadaNot yet recruiting
200 Elizabeth Street
Coordinator of this site? Confirm its status
TorontoCanadaRecruiting
Sunnybrook Health Sciences Center
Coordinator of this site? Confirm its status
TorontoCanadaNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.